Source: FDA, National Drug Code (US) Revision Year: 2020
NURTEC ODT contains rimegepant sulfate, a calcitonin gene-related peptide receptor antagonist. Rimegepant sulfate is described chemically as (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)-1-piperidinecarboxylate hemisulfate sesquihydrate and its structural formula is:
Its empirical formula is C28H28F2N6O3 0.5 H2SO4 1.5 H2O, representing a molecular weight of 610.63. Rimegepant free base has a molecular weight of 534.56. Rimegepant sulfate is a white to off-white, crystalline solid that is slightly soluble in water.
NURTEC ODT (orally disintegrating tablets) is for sublingual or oral use and contains 85.65 mg rimegepant sulfate, equivalent to 75 mg rimegepant free base, and the following inactive ingredients: benzyl alcohol, eucalyptol, gelatin, limonene, mannitol, menthol, menthone, menthyl acetate, sucralose, and vanillin.
| Dosage Forms and Strengths |
|---|
|
NURTEC ODT Orally disintegrating tablets: white to off-white, circular, and debossed with the symbol |
| How Supplied |
|---|
|
NURTEC ODT 75 mg orally disintegrating tablets are white to off-white, circular, debossed with the symbol ?renderMultiMedia?, and supplied in cartons containing a blister pack of 8 orally disintegrating tablets. Each ODT contains 75 mg rimegepant. NDC: 72618-3000-2 |
| Drug | Countries | |
|---|---|---|
| NURTEC ODT | Israel, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
, each containing 75 mg of rimegepant.